Delivery Order SPE2DB20D3103-SPE2DB25FQ0F3
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30. This contract, valued at $6,240.24, represents a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $39,326.10 and an ultimate completion date of September 9, 2025. The contract carries no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $37,364.76, with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,448.37 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) with an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $24,781.68 delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets in quantities of 30, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,240.24 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units) with a firm fixed price and no set-aside designation. The contract was awarded on November 7, 2025, with an ultimate completion date of November 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $8,260.56 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dasatinib is a tyrosine kinase inhibitor used in the treatment of certain leukemias and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dasatinib 50 mg tablets (60-count units) valued at $26,409.82. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dasatinib is a targeted cancer therapy medication commonly used to treat chronic myeloid leukemia and other...
- The Defense Logistics Agency awarded a delivery order valued at $47,320.66 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Dasatinib 100 mg tablets in a 30-count package, with a contract ceiling value of $4,816.96. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and is scheduled for completion by April 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...